RBC Capital Starts Neos Therapeutics (NEOS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
August 17, 2015 7:39 AM EDTBMO Capital initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with an Outperform rating and a price target of $26.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... MoreJMP Securities Starts Neos Therapeutics (NEOS) at Market Outperform
August 17, 2015 7:37 AM EDTJMP Securities initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with a Market Outperform rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... More


